Stryker Historical Cash Flow
| SYK Stock | USD 371.11 0.00 0.00% |
Analysis of Stryker cash flow over time is an excellent tool to project Stryker future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Depreciation of 1.1 B or Other Non Cash Items of 357 M as it is a great indicator of Stryker ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Stryker latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Stryker is a good buy for the upcoming year.
Stryker |
About Stryker Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Stryker balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Stryker's non-liquid assets can be easily converted into cash.
Stryker Cash Flow Chart
Add Fundamental
Free Cash Flow
The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.Change In Working Capital
The difference in the amount of working capital from one period to the next, indicating the change in a company's short-term assets and liabilities.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Depreciation
Depreciation indicates how much of Stryker value has been used up. For tax purposes Stryker can deduct the cost of the tangible assets it purchases as business expenses. However, Stryker must depreciate these assets in accordance with IRS rules about how and when the deduction may be taken, and how long it will last. The systematic allocation of the cost of a tangible asset over its useful life.Most accounts from Stryker's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Stryker current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Stryker. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. For more information on how to buy Stryker Stock please use our How to buy in Stryker Stock guide.At this time, Stryker's Other Non Cash Items is quite stable compared to the past year. Capital Expenditures is expected to rise to about 792.8 M this year, although the value of Total Cash From Financing Activities is projected to rise to (498.8 M).
| 2022 | 2023 | 2024 | 2025 (projected) | Dividends Paid | 1.1B | 1.1B | 1.2B | 1.3B | Stock Based Compensation | 168M | 205M | 229M | 240.5M |
Stryker cash flow statement Correlations
Click cells to compare fundamentals
Stryker Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Stryker cash flow statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change To Inventory | 27M | (189M) | (762M) | (797M) | 46M | 48.3M | |
| Change In Cash | (1.4B) | 1M | (1.1B) | 1.1B | 681M | 715.1M | |
| Free Cash Flow | 2.8B | 2.7B | 2.0B | 3.1B | 3.5B | 3.7B | |
| Change In Working Capital | 866M | 279M | (732M) | (500M) | (683M) | (648.9M) | |
| Begin Period Cash Flow | 4.3B | 2.9B | 2.9B | 1.8B | 3.0B | 3.1B | |
| Other Cashflows From Financing Activities | 3.1B | (264M) | 955M | (178M) | (246M) | (233.7M) | |
| Depreciation | 812M | 990M | 998M | 1.0B | 1.1B | 1.1B | |
| Other Non Cash Items | (190M) | 66M | (226M) | 19M | 340M | 357M | |
| Capital Expenditures | 487M | 525M | 588M | 575M | 755M | 792.8M | |
| Total Cash From Operating Activities | 3.3B | 3.3B | 2.6B | 3.7B | 4.2B | 4.5B | |
| Net Income | 1.6B | 2.0B | 2.4B | 3.2B | 3.0B | 3.1B | |
| Total Cash From Financing Activities | (11M) | (2.4B) | (749M) | (1.6B) | (525M) | (498.8M) | |
| End Period Cash Flow | 2.9B | 2.9B | 1.8B | 3.0B | 3.7B | 3.8B | |
| Stock Based Compensation | 142M | 171M | 168M | 205M | 229M | 240.5M | |
| Dividends Paid | 863M | 950M | 1.1B | 1.1B | 1.2B | 1.3B | |
| Sale Purchase Of Stock | (110M) | (114M) | (122M) | (155M) | (178.3M) | (187.2M) | |
| Change To Account Receivables | 354M | (377M) | (579M) | (175M) | (321M) | (305.0M) | |
| Change To Liabilities | (106M) | 13M | 325M | 223M | 200.7M | 210.7M | |
| Change To Netincome | 320M | 453M | 464M | 454M | 522.1M | 548.2M | |
| Other Cashflows From Investing Activities | (4.2B) | 5M | (2.3B) | 1M | 43M | 45.2M | |
| Total Cashflows From Investing Activities | (1.5B) | (4.7B) | (859M) | (2.9B) | (2.6B) | (2.8B) | |
| Investments | 7M | (859M) | (2.9B) | (972M) | (3B) | (2.9B) | |
| Change Receivables | (563M) | 354M | (377M) | (579M) | (521.1M) | (495.0M) | |
| Net Borrowings | 1.3B | 989M | (1.2B) | 472M | 542.8M | 881.2M | |
| Cash And Cash Equivalents Changes | 721M | (1.4B) | 39M | (1.0B) | (944.1M) | (896.9M) | |
| Cash Flows Other Operating | 79M | 19M | 56M | (68M) | (61.2M) | (58.1M) | |
| Change To Operating Activities | (177M) | 866M | 279M | 64M | 73.6M | 77.3M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out World Market Map to better understand how to build diversified portfolios, which includes a position in Stryker. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. For more information on how to buy Stryker Stock please use our How to buy in Stryker Stock guide.You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Stryker. If investors know Stryker will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Stryker listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.53) | Dividend Share 3.24 | Earnings Share 7.76 | Revenue Per Share | Quarterly Revenue Growth 0.107 |
The market value of Stryker is measured differently than its book value, which is the value of Stryker that is recorded on the company's balance sheet. Investors also form their own opinion of Stryker's value that differs from its market value or its book value, called intrinsic value, which is Stryker's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Stryker's market value can be influenced by many factors that don't directly affect Stryker's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Stryker's value and its price as these two are different measures arrived at by different means. Investors typically determine if Stryker is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Stryker's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.